ondansetron has been researched along with Anoxia, Brain in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dergacheva, O | 1 |
| Kamendi, H | 1 |
| Wang, X | 1 |
| Pinol, RA | 1 |
| Frank, J | 1 |
| Gorini, C | 1 |
| Jameson, H | 1 |
| Lovett-Barr, MR | 1 |
| Mendelowitz, D | 1 |
1 other study available for ondansetron and Anoxia, Brain
| Article | Year |
|---|---|
5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia.
Topics: Animals; Disease Models, Animal; Excitatory Postsynaptic Potentials; Heart; Hypoxia, Brain; Ketanser | 2009 |